Welcome to our dedicated page for Livecare news (Ticker: LVCE), a resource for investors and traders seeking the latest updates and insights on Livecare stock.
LiveCare Inc. (LVCE) generates news as a telehealth and healthcare technology company focused on remote patient monitoring, health coaching, and chronic disease management. Coverage of LiveCare often centers on its programs for individuals with Type 2 diabetes, high blood pressure, hypertension, congestive heart failure, and other chronic conditions, delivered through 24/7 telehealth support and connected monitoring devices.
News updates frequently highlight patient growth milestones, expansion of services into additional U.S. states, and efforts to extend telehealth offerings nationwide. Articles also describe LiveCare’s development and launch of a blood pressure cuff device designed for people with high blood pressure and related conditions, as well as its broader use of non-invasive monitoring technologies linked to its health center and live professionals.
Investors and observers can find reports on LiveCare’s financial and operational milestones, including recurring monthly revenue achievements, patient acquisition metrics, and stated goals related to profitability and aspirations to become a fully reporting NASDAQ entity. The company’s expansion initiatives into markets such as Florida, Texas, Ohio, Michigan, California, and the Gulf region via provisional approval in Dubai Healthcare City are also recurring themes.
Another important category of news involves regulatory and compliance developments. LiveCare has publicly discussed identifying potential non-compliance with Medicare rules, conducting an internal investigation, self-disclosing concerns about marketing practices, and cooperating with a U.S. Department of Justice investigation involving the Anti-Kickback Statute and the False Claims Act, which the company reports has been resolved with corrective actions in place.
This news page allows readers to follow LiveCare’s announcements on telehealth services, chronic disease programs, technology initiatives, geographic expansion, and compliance matters over time.
LiveCare OTC:LVCE aims to enhance its telehealth services, specifically targeting Type II diabetes and elder care. The company, founded in 2018, has successfully scaled its remote health monitoring services, now servicing hundreds of members. With an active Regulation A offering and plans to uplist to OTCQB, LiveCare is positioned for growth. Its model relies on direct-to-consumer marketing and Medicare billing, ensuring no out-of-pocket costs for services. Future expansions include a program to support elderly care at home, leveraging technology to reduce institutionalization rates.